Impaired beta-cell function in the Chinese hamster CHIG/Han subline

Area of Science:

• Endocrinology
• Metabolic Diseases
• Animal Models of Diabetes

Background:

• Genetically diabetic CHIG/Han hamsters display varying glycemia levels.
• Diabetes-resistant CHIA/Han hamsters serve as a control group.

Purpose of the Study:

• To investigate the pancreatic islet dysfunction in CHIG/Han hamsters.
• To correlate islet abnormalities with plasma glucose and insulin levels.

Main Methods:

• Measurement of plasma glucose and insulin.
• Histological analysis (light microscopy, immunohistochemistry) of pancreatic islets.
• Static incubation of isolated islets to assess insulin secretion.
• Pharmacological intervention with 3-isobutyl-1-methylxanthine (IBMX).

Main Results:

• Severely diabetic CHIG hamsters showed attenuated hyperinsulinemia, beta-cell degranulation, and loss of insulin.
• Islets from diabetic hamsters had increased basal insulin release and deficient glucose-stimulated insulin release.
• Significant decreases in islet insulin content were observed in diabetic hamsters.
• IBMX enhanced insulin release in non-diabetic and mildly diabetic hamsters but not in severely diabetic ones.
• A negative correlation was found between islet insulin content and plasma glucose levels.

Conclusions:

• Reduced secretory capacity and decreased insulin content in islets are early signs of beta-cell dysfunction in CHIG/Han hamsters.
• These islet abnormalities contribute to the diabetic phenotype in this genetic model.
• The findings highlight the progressive nature of islet dysfunction in diabetes development.